Skip to main content
. 2021 Sep 8;11(9):899. doi: 10.3390/jpm11090899

Figure 1.

Figure 1

Performance and analytical sensitivity of the panel. Correlation between expected allelic frequencies for reported variants in commercial standard control samples and those observed by the assay: (A) FFPE Horizon Discovery sample (HD 200); (B) germline DNA samples with BRCA1/2 mutations (HD 793 and HD 794).